ClinicalTrials.Veeva

Menu

Comparing the Effectiveness of Individual vs. Household Treatment for Scabies in Lambaréné, Gabon

C

Centre de Recherche Médicale de Lambaréné

Status and phase

Completed
Phase 4

Conditions

Households
Scabies

Treatments

Drug: Benzyl Benzoate 25% Topical Application Lotion

Study type

Interventional

Funder types

Other

Identifiers

NCT04205669
GrattiGratta31082018

Details and patient eligibility

About

It is unclear whether individual treatment of scabies is similarly effective compared to household treatment. This study therefore compares these two treatment strategies with topical benzyl benzoate for treating scabies in Lambaréné and surroundings in Gabon.

Subjects presenting with uncomplicated scabies are randomized into either the Individual Treatment group, where only the affected subjects receive treatment, or the Household Treatment group, where all family members are treated in parallel to the affected subjects regardless of signs and symptoms. The primary endpoint is clinical cure after 28 days; the secondary endpoint is the proportion of affected household members per household after 28 days.

Enrollment

104 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosed with active, uncomplicated scabies
  • no known hypersensitivity or allergy against benzyl benzoate

Exclusion criteria

  • hypersensitivity or allergy against benzyl benzoate
  • severe superinfection of scabies lesions

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

104 participants in 2 patient groups

Individual Treatment
Active Comparator group
Treatment:
Drug: Benzyl Benzoate 25% Topical Application Lotion
Household Treatment
Active Comparator group
Treatment:
Drug: Benzyl Benzoate 25% Topical Application Lotion

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems